首都医科大学学报 ›› 2016, Vol. 37 ›› Issue (5): 597-601.doi: 10.3969/j.issn.1006-7795.2016.05.008

• 消化内镜新进展 • 上一篇    下一篇

如何更有效的采用血管内联合血管旁注射聚桂醇治疗食管静脉曲张

许昌芹, 刘慧, 许洪伟   

  1. 山东大学附属省立医院消化科, 济南 250021
  • 收稿日期:2016-07-20 出版日期:2016-10-21 发布日期:2016-10-19
  • 通讯作者: 许洪伟 E-mail:xu_hong_wei@sina.com
  • 基金资助:
    山东省自然科学基金(ZR2014HM106),山东省科技发展计划(2013YD18052)。

How to improve the efficacy of endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal varices

Xu Changqin, Liu Hui, Xu Hongwei   

  1. Department of Gastroenterology, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China
  • Received:2016-07-20 Online:2016-10-21 Published:2016-10-19
  • Supported by:
    This study was supported by Shandong Province Natural Science Foundation (ZR2014HM106), Science and Technology Development Project of Shandong Province(2013YD18052).

摘要: 目的 探讨血管内联合血管旁注射聚桂醇治疗食管静脉曲张的临床疗效及提高疗效的措施。方法 回顾性分析近6年来行内镜下食管静脉曲张硬化剂注射(endoscopic injection sclerotherapy,EIS)治疗的患者260人,EIS采用血管内联合血管旁注射的方法,观察其急症止血、食管静脉曲张好转等疗效以及合并症。结果 1EIS治疗疗效与治疗次数明显相关,每次治疗与前一次治疗相比均有明显的疗效(P≤0.001),静脉曲张好转率随治疗次数增加而提高,连续4次及以上治疗后静脉曲张缓解率可达96.55%(28/29),恢复到轻度甚至消失者可达82.76%(24/29)。2急症内镜下止血69例,成功率94.20%(65/69)。3治疗的合并症包括早期再出血13例,迟发性再出血27例,较为严重的合并症4例,包括2例食管黏膜糜烂、脱落至出血和2例食管狭窄,均予以相应的治疗后好转。结论 血管内联合血管旁注射聚桂醇可有效进行食管静脉曲张破裂出血的急症内镜下止血,短间隔多次治疗可有效提高食管静脉曲张缓解率并预防出血,且安全性较高。

关键词: 食管静脉曲张, 聚桂醇, 内镜下硬化治疗, 血管内联合血管旁

Abstract: Objective To investigate the efficacy of Endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal variceal and the methods to improve the efficacy. Methods We retrospectively analyzed the 260 patients who underwent endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy. Then we observed the efficacy for emergency hemostasis and remission and complications of the endoscopic injection sclerotherapy (EIS). Results ①The efficacy of the therapy was associated with the times of therapies. The efficacy of therapy for every time was very significant (P≤0.001). The rate of esophageal varices remission was 96.55% (28/29) and that of recovery to G1 or disappeared was 82.76% (24/29) after four times of therapies. ②Success rate of emergency endoscopic hemostatis was 94.20% (65/69).③Thirteen patients with early rebleeding and 27 patients with late rebleeding, 4 patients had complications including 2 patients with esophageal mucosal erosion and bleeding and 2 patients with esophageal stenosis, they received treatments and recovered. Conclusion Endoscopic intravariceal plus paravariceal injection lauromacrogol sclerotherapy for treatment of esophageal varices was effective and safe, and the efficacy can be improved with more times of treatments and short intervals.

Key words: esophageal varices, lauromacrogol, endoscopic injection sclerotherapy, intravariceal and paravariceal

中图分类号: